337 filings
Page 2 of 17
S-8
ybbxi6t6wq3j5jhwj
2 Aug 23
Registration of securities for employees
4:34pm
8-K
3vmqi
2 Aug 23
Pacira BioSciences Reports Second Quarter 2023 Financial Results
8:02am
8-K
xm5koz2a01a0
20 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
p4xroe1uu dn0q5db
3 May 23
Pacira BioSciences Reports First Quarter 2023 Financial Results
8:02am
ARS
8pejw68a49npjlkpy
21 Apr 23
Annual report to shareholders
4:12pm
DEFA14A
zsokc7vi
21 Apr 23
Additional proxy soliciting materials
4:08pm
8-K
fvxz y6stctynyi
3 Apr 23
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using
8:02am
8-K
dchryf30k64
22 Mar 23
Pacira BioSciences Announces Departure of Yvonne Greenstreet from Board of Directors
8:01am
8-K
rmfo0 lrxoi3vfl1dj
28 Feb 23
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
8:03am
8-K
hbbmg3gheknmrpu9m223
5 Jan 23
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
4:31pm
8-K
5rwdapgl
13 Dec 22
Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022
8:02am
8-K
kcyyjbgcfc8llfjq2d
14 Nov 22
Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022
8:01am
8-K
xfj5eu6
3 Nov 22
Pacira BioSciences Reports Third Quarter 2022 Financial Results
8:08am
8-K
ukcoxz285f650y60
13 Oct 22
Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million
8:02am
8-K
2tchy2a6p ce
13 Sep 22
Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 2022
8:01am